Back to top
more

Merit Medical Systems (MMSI)

(Real Time Quote from BATS)

$95.98 USD

95.98
200,811

-1.48 (-1.52%)

Updated Sep 10, 2024 02:24 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 30% (174 out of 250)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

HSIC or MMSI: Which Is the Better Value Stock Right Now?

HSIC vs. MMSI: Which Stock Is the Better Value Option?

Merit Medical (MMSI) Hits 52-Week High: What's Driving the Stock?

Investors are optimistic about Merit Medical's (MMSI) strong product portfolio.

SmileDirectClub (SDC) Down 25.6% Since Last Earnings Report: Can It Rebound?

SmileDirectClub (SDC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Merit Medical (MMSI) Down 0.7% Since Last Earnings Report: Can It Rebound?

Merit Medical (MMSI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Merit Medical's (MMSI) New Launch to Boost its Product Suite

Merit Medical's (MMSI) latest addition to its Vascular portfolio is expected to significantly enhance patient outcomes.

Here's Why You Should Retain Merit Medical (MMSI) Stock for Now

Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.

CVS Health's (CVS) New Acquisitions Aid, Cost Woes Linger

CVS Health (CVS) launches functionality that gives patients more choices and convenience in filling prescriptions.

IDEXX (IDXX) Global Sales, Instrument Placement Robust

IDEXX (IDXX) continues to demonstrate solid growth globally, primarily aided by a gain in CAG and Water businesses.

MMSI vs. WST: Which Stock Is the Better Value Option?

MMSI vs. WST: Which Stock Is the Better Value Option?

Merit Medical (MMSI) Q4 Earnings Top Estimates, Margins Down

Merit Medical (MMSI), in the fourth quarter, benefits from revenue growth in its Cardiovascular segment and the majority of product categories within its Cardiovascular unit.

Merit Medical (MMSI) Q4 Earnings and Revenues Surpass Estimates

Merit Medical (MMSI) delivered earnings and revenue surprises of 17.91% and 1.26%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Walgreens' (WBA) New Partnerships Aid, Margin Pressure Ails

Walgreens Boots (WBA) raises its U.S. Healthcare target, including fiscal 2025 sales goal.

3 Reasons to Retain Inogen (INGN) Stock in Your Portfolio

Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.

Staar Surgical (STAA) Lags Q4 Earnings and Revenue Estimates

Staar Surgical (STAA) delivered earnings and revenue surprises of -6.67% and 0.50%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Quest Diagnostics (DGX) Base Business Growth Robust, Volume Up

Quest Diagnostics (DGX) starts to benefit from incentives related to these value-based contracts, which help demonstrate the value of these strategic relationships.

Medtronic (MDT) Receives CE Mark Approval For Aurora System

Medtronic (MDT) Aurora EV-ICD system indicated for patients at risk of life-threatening arrhythmias.

Debanjana Dey headshot

MedTech Stocks' Q4 Earnings on Feb 22: FMS, GKOS & More

MedTech companies' Q4 results are likely to reflect strength in customer demand. Let's see how FMS, GKOS, MMSI and DVA are placed ahead of their earnings releases.

Reasons to Retain Patterson Companies (PDCO) Stock Now

Investors are optimistic about Patterson Companies' (PDCO) strong product line.

Here's Why You Should Retain Masimo (MASI) Stock for Now

Investors continue to be optimistic about Masimo (MASI) due to its focus on patient monitoring.

Here's Why You Should Retain Neogen (NEOG) Stock for Now

Investors are optimistic about Neogen's (NEOG) strong performance across its Animal Safety and Food Safety segments.

Here's Why You Should Retain Abbott (ABT) Stock for Now

Investors are optimistic about Abbott (ABT) owing to continued growth in the Diabetes business.

Edwards Lifesciences (EW) Gains on Innovation, Margin Growth

In Edwards Lifesciences' (EW) Smart Recovery portfolio, the adoption of FloTrac and ClearSight sensors remains strong.

Here's Why You Should Retain Inari Medical (NARI) Stock Now

Inari Medical (NARI) continues benefiting from its commitment to understand the venous system. However, dependency on the wide adoption of products is a concern.

Here's Why You Should Retain OPKO Health (OPK) Stock for Now

Investors continue to be optimistic about OPKO Health (OPK) owing to its potential in RAYALDEE.

Boston Scientific (BSX) Gains From New Buyouts, Cost Woes Stay

Boston Scientific's (BSX) EMEA business grows above market, supported by the company's ongoing investments in emerging markets.